erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Obesity D009765 29 associated lipids
Bradycardia D001919 13 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Salpingitis D012488 2 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Mortensen JE and McDowell T Streptococcus pyogenes: resistant, tolerant, neither or both? 1995 Adv. Exp. Med. Biol. pmid:8718606
Ferraro AL et al. The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area. 1995 Adv. Exp. Med. Biol. pmid:8718607
Klein TW et al. Legionella pneumophila infection and cytokine production. 1992 Adv. Exp. Med. Biol. pmid:1414610
Jasir A and Schalén C Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci. 1997 Adv. Exp. Med. Biol. pmid:9331689
Savoia D et al. Group A streptococci. Erythromycin resistance and penicillin tolerance. 1997 Adv. Exp. Med. Biol. pmid:9331690
Vicarini H et al. Analysis of regulatory region of ermAM genes in streptococci and enterococci highly resistant to macrolides and lincosamides. 1997 Adv. Exp. Med. Biol. pmid:9331702
Lartey PA et al. New developments in macrolides: structures and antibacterial and prokinetic activities. 1994 Adv. Pharmacol. pmid:8080820
Garrett RA and Wittmann HG Structure of bacterial ribosomes. 1973 Adv. Protein Chem. pmid:4589667
Dully FE Streptococcal epidemic in an aircraft carrier. 1973 Aerosp Med pmid:4201795
Ogwal S and Xide TU Bioavailability and stability of erythromycin delayed release tablets. 2001 Afr Health Sci pmid:12789122
Olatunji FO et al. Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria. 2007 Afr J Med Med Sci pmid:18390064
Campbell G et al. A cautionary tale: delayed onset rhabdomyolysis due to erythromycin/simvastatin interaction. 2007 Age Ageing pmid:17913761
Haboubi NY et al. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. 1991 Age Ageing pmid:2028847
Roddis MJ Antibiotic-associated colitis: a retrospective study of fifteen cases. 1978 Age Ageing pmid:101026
Carević O and Djokić S Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. 1988 Agents Actions pmid:2847507
Friedman GD and Selby JV Epidemiological screening for potentially carcinogenic drugs. 1990 Agents Actions Suppl. pmid:2316434
LIGNY G and VIGUIE R [DESTRUCTION OF THE INTESTINAL FLORA BY ANTIBIOTIC THERAPY]. 1964 May-Jun Agressologie pmid:14185522
Hashiba H et al. Transformation of Lactobacillus helveticus subsp. jugurti with plasmid pLHR by electroporation. 1990 Agric. Biol. Chem. pmid:1368569
Chen SZ et al. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. 2005 Ai Zheng pmid:16086867
Takei M et al. [Studies on the mixed culture of Candida and Lactobacillus. 3. Influences of the antibiotics (EM and TM)]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5236280
Sugiyama H [Experimental studies on control of dental caries. 1. Preventive effect of Erythromycin]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5244796
Sugiyama H [Experimental studies on control of dental caries. 2. Erythromycin and oral microbial flora]. 1968 Aichi Gakuin Daigaku Shigakkai Shi pmid:5261349
van der Wouw PA et al. Disseminated cat-scratch disease in a patient with AIDS. 1989 AIDS pmid:2515881
Taha TE et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. 2006 AIDS pmid:16816561
Berger TG and Koehler JE Bacillary angiomatosis. 1993-1994 AIDS Clin Rev pmid:8217903
Schlecht HP et al. Images in HIV/AIDS. HIV-associated lymphogranuloma venereum proctitis. 2007 AIDS Read pmid:17396331
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs. 2004 AIDS Treat News pmid:15595151
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Haans JJ and Masclee AA Review article: The diagnosis and management of gastroparesis. 2007 Aliment. Pharmacol. Ther. pmid:18081647
McCallum RW and Cynshi O Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. 2007 Aliment. Pharmacol. Ther. pmid:17894654
Winstead NS and Wilcox CM Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. 2007 Aliment. Pharmacol. Ther. pmid:17848180
Bell GD et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. 1992 Aliment. Pharmacol. Ther. pmid:1486161
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Annese V et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. 1997 Aliment. Pharmacol. Ther. pmid:9218089
Chiba T et al. Motilides accelerate regional gastrointestinal transit in the dog. 2000 Aliment. Pharmacol. Ther. pmid:10886053
Landry C et al. Could oral erythromycin optimize high energy continuous enteral nutrition? 1996 Aliment. Pharmacol. Ther. pmid:8971296
Curry JI et al. Review article: erythromycin as a prokinetic agent in infants and children. 2001 Aliment. Pharmacol. Ther. pmid:11328252
Kendall BJ et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9146779
Boecxstaens V et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. 2011 Aliment. Pharmacol. Ther. pmid:21517922